Objectives: Tuberous sclerosis complex (TSC) may affect multiple systems, but few prenatal symptoms appear during pregnancy. With development of high-throughput DNA sequencing technology, two TSC genes have been proposed as an independent diagnostic standard. This study aimed to determine prenatal tubercular sclerosis diagnosis and counselling for high-risk groups of TSC using high-throughput DNA sequencing combined with fetal heart echocardiography (FE). Methods: FE was performed in 28 pregnant women with a family history of TSC or suspected familial tuberous sclerosis. Amniotic fluid and peripheral blood samples were collected from pregnant women or their family members. Fetuses and family members were further analysed for potential TSC1 and TSC2 mutations by next-generation DNA sequencing. Results: 28 families were selected. Twenty-seven families had members and/or probands with TSC gene abnormalities, of which five were family genetic mutations and 22 were caused by de novo mutations. For prenatal diagnosis, TSC gene abnormalities were detected in five of 28 fetal amniotic fluid samples. Among these samples, three had multiple cardiac rhabdomyoma (CR) by FE and the remaining samples were negative by FE. One special family, the proband was clinically diagnosed with TSC, but no target genes was identified in the whole family. Conclusions: For high-risk TSC population, target gene detection combined with FE for prenatal diagnosis of TSC is feasible. Counselling, prognosis and perinatal management are facilitated based on genetic analysis and FE.
OP16.06
Quality assessment of (semi-) automated evaluation of the fetal heart using fetal intelligent navigation echocardiography (FINE) in 700 cases Schleswig-Holstein, Campus Luebeck, Luebeck, Schleswig-Holstein, Germany Objectives: To evaluate the performance of (semi-) automated sonographic evaluation of the fetal heart using FINE software in fetuses presenting in favourable and non-favourable positions. Methods: Prospective analysis of the correct depiction of the 9 standard planes in STIC volumes with fetal spine position during initial volume acquisition at 2 and 10 o'clock, 3 and 9 o'clock, 4 and 8 o'clock, 5 and 7 o'clock and at 6 o'clock. Results: Between 04/2015 -03/2017 706 STIC (5D Heart) volumes in fetuses with a mean gestational age of 20 5/7 gestational weeks (14 0/7 -32 0/7 gw) were acquired. The sample consisted of 39 volumes acquired with the fetal spine at 2 and 10 o'clock, 78 volumes at 3 and 9 o'clock, 229 volumes at 4 and 8 o'clock and 360 volumes with the fetal spine between 5 and 7 o'clock.
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When using a non-recommended fetal position for acquisition of 5DHeart volumes, with the fetal spine located outside 5-7 o'clock, correct visualisation of a least 8 of the 9 diagnostic planes was achieved as shown in table 1. Frequently not complete depicted planes are also shown in the table.
Multiple logistic regression model proofed significant difference between favourable and non-favourable spine position and correctly depicted planes and in cases of advanced gestational age. Conclusions: FINE -software is feasible and reasonable applicable even in a non-favourable fetal presentation.
Main reasons for impaired visualisation were shadowing of bones and if key heart structures were orientated parallel to the insonation angle.
OP16.07
Fetal intelligent navigation echocardiography (FINE) detects congenital heart disease with a sensitivity of 98%, specificity of 93% and accuracy of 95% Objectives: Fetal Intelligent Navigation Echocardiography (FINE) is a novel method that automatically generates and displays nine standard fetal echocardiography views in normal hearts by applying intelligent navigation technology to spatiotemporal image correlation (STIC) volume datasets. The objective of this study was to determine the sensitivity, specificity, and accuracy of FINE in the prenatal detection of congenital heart disease (CHD). Methods: A case-control study was conducted in 50 fetuses with confirmed CHD (cases) and 100 fetuses with normal hearts (controls) in the second and third trimesters (1:2 ratio). Using four-dimensional ultrasound with STIC technology, volume datasets containing gray-scale information were acquired in these fetuses. After all identifying information was removed from 150 volume datasets, they were randomly distributed to a different sonologist for analysis using the FINE method. The sonologist was blinded to the fetal cardiac diagnosis, and did not acquire any of the STIC volumes. The sensitivity, specificity, and accuracy of FINE for the prenatal detection of CHD were determined. Results: The CHD diagnoses included septal defects, atrioventricular septal defects, conotruncal anomalies (double outlet right ventricle, tetralogy of Fallot, transposition of the great vessels), right heart anomalies, left heart anomalies, and other cardiac defects. The sensitivity, specificity, and accuracy of FINE for the prenatal detection of CHD was 98% (49/50), 93% (93/100), and 95% (142/150), respectively. Conclusions: We present herein for the first time the diagnostic accuracy of the FINE method in fetuses with normal hearts and CHD in the second to third trimesters. Since FINE accurately identifies a broad spectrum of CHD, this method could be used prenatally to screen for and diagnose CHD. ''drop-out'' planes 
